Doppler Ultrasound Flowmetry Predicts 15 Year Outcome in Patients with Skin Melanoma
Overview
Authors
Affiliations
Unlabelled: This prospective cohort study was conducted to find the role of tumor neovascularization in skin melanoma measured by preoperative Doppler ultrasound flowmetry in determining the 15-year outcome.
Setting: Department of Surgery, University of Wales College of Medicine, Cardiff, UK. Seventy-one primary melanomas in 67 patients were studied with a 10 MHz Doppler ultrasound flowmeter. The flow signals were recorded on an audiotape. The peak systolic frequency, mean systolic frequency, and minimum diastolic frequency were measured on a spectrum analyzer. The follow-up (median 144 months) information is complete till December 2005 on 63 patients. Blood flow signals were detected in 41 lesions; these were labeled Doppler flow positive. No flow was detected in 22 lesions, labeled Doppler flow negative. Among the Doppler flow positive group, 39% patients have died with metastatic melanoma, whereas none of the patients with a Doppler-negative lesion have died or developed any recurrence. Higher peak systolic frequency (above 2,500 MHz.) was associated with a hazard ratio for death due to melanoma of (HAZARD RATE = 5.99). Higher risk of death, locoregional, and systemic recurrences were associated with higher peak systolic frequency. Doppler flowmetry performed preoperatively is a noninvasive, quick, and simple method to assess tumor blood flow which may help in predicting long-term survival and planning neoadjuvant therapies aimed at inhibiting angiogenesis or targeting tumor vasculature.
Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung S, Nathan P, Matin R Cochrane Database Syst Rev. 2019; 7:CD012806.
PMID: 31260100 PMC: 6601698. DOI: 10.1002/14651858.CD012806.pub2.
Corvino A, Sandomenico F, Corvino F, Campanino M, Verde F, Giurazza F J Ultrasound. 2019; 23(1):45-53.
PMID: 30927249 PMC: 7010871. DOI: 10.1007/s40477-019-00376-3.
Scotto di Santolo M, Massimo C, Tortora G, Romeo V, Amitrano M, Brunetti A Radiol Med. 2019; 124(6):568-574.
PMID: 30612252 DOI: 10.1007/s11547-018-0969-1.
Schuster C, Akslen L, Stokowy T, Straume O J Pathol Clin Res. 2018; 5(1):53-62.
PMID: 30225999 PMC: 6317286. DOI: 10.1002/cjp2.116.
Scotto di Santolo M, Sagnelli M, Tortora G, Santoro M, Canta P, Molea G Radiol Med. 2016; 121(6):521-7.
PMID: 26847049 DOI: 10.1007/s11547-016-0621-x.